Grifols reports €227 million profit by June, up 28.7%, and improves its financial position
Grifols earned €227 million in the first half of 2026, a 28.7% increase, and refinanced its 2027 debt under better conditions.
Latest Grifols news
8 articles
Ibex 35 drops 1.55% to 19,422 points on a day of results. CaixaBank plunges 6.48% and Telefónica 2.95%, while Grifols rises 7.18%.
Grifols earned €227 million in the first half of 2026, a 28.7% increase, and refinanced its 2027 debt under better conditions.
Grifols expects albumin revenue to stabilise in the second half of 2026 after a 14% drop in the first half due to price adjustments in China.
Grifols reports a €227 million profit in the first half, up 28.7%, driven by immunoglobulins and operational recovery.
Grifols earns €227 million in the first half of 2026, 28.7% more, despite a 3% revenue drop to €3.574 billion.
Grifols earns 227 million in the first half, a 28.7% increase, despite a 3% revenue drop due to currency effects. The Catalan pharmaceutical improves its EBITDA by 2%.
Ibex-35 falls 0.05% to 19,206.9 points, with Grifols (+3.72%) and Solaria (+1.78%) as rising stocks amid geopolitical tensions.
Ibex 35 closes flat at 19,206 points, focused on corporate earnings and ECB meeting amid geopolitical tension between the US and Iran.